For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Opko Health Inc (NASDAQ: OPK) closed at $1.27 in the last session, up 0.79% from day before closing price of $1.26. In other words, the price has increased by $0.79 from its previous closing price. On the day, 2.75 million shares were traded. OPK stock price reached its highest trading level at $1.295 during the session, while it also had its lowest trading level at $1.245.
Ratios:
We take a closer look at OPK’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.02 and its Current Ratio is at 3.41. In the meantime, Its Debt-to-Equity ratio is 0.31 whereas as Long-Term Debt/Eq ratio is at 0.29.
On June 29, 2023, Barrington Research Upgraded its rating to Outperform which previously was Mkt Perform but kept the price unchanged to $2.
On December 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $3.H.C. Wainwright initiated its Buy rating on December 15, 2022, with a $3 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 10 ’25 when FROST PHILLIP MD ET AL bought 125,000 shares for $1.36 per share. The transaction valued at 169,712 led to the insider holds 214,001,448 shares of the business.
FROST PHILLIP MD ET AL bought 125,000 shares of OPK for $184,650 on Apr 08 ’25. The CEO & Chairman now owns 213,876,448 shares after completing the transaction at $1.48 per share. On Apr 01 ’25, another insider, FROST PHILLIP MD ET AL, who serves as the CEO & Chairman of the company, bought 100,000 shares for $1.65 each. As a result, the insider paid 164,850 and bolstered with 213,751,448 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OPK now has a Market Capitalization of 1008104384 and an Enterprise Value of 1136564096. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.52 while its Price-to-Book (P/B) ratio in mrq is 0.76. Its current Enterprise Value per Revenue stands at 1.712 whereas that against EBITDA is -6.576.
Stock Price History:
The Beta on a monthly basis for OPK is 1.39, which has changed by -0.11188811 over the last 52 weeks, in comparison to a change of 0.19283521 over the same period for the S&P500. Over the past 52 weeks, OPK has reached a high of $2.04, while it has fallen to a 52-week low of $1.11. The 50-Day Moving Average of the stock is -4.95%, while the 200-Day Moving Average is calculated to be -14.90%.
Shares Statistics:
According to the various share statistics, OPK traded on average about 3.26M shares per day over the past 3-months and 3173610 shares per day over the past 10 days. A total of 779.78M shares are outstanding, with a floating share count of 350.50M. Insiders hold about 55.84% of the company’s shares, while institutions hold 31.45% stake in the company. Shares short for OPK as of 1752537600 were 32409499 with a Short Ratio of 9.95, compared to 1749772800 on 30996173. Therefore, it implies a Short% of Shares Outstanding of 32409499 and a Short% of Float of 7.17.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.09 and low estimates of -$0.09.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is -$0.35, with 1 analysts recommending between -$0.35 and -$0.35.
Revenue Estimates
According to 6 analysts, the current quarter’s revenue is expected to be $161.62M. It ranges from a high estimate of $167.7M to a low estimate of $136M. As of the current estimate, Opko Health Inc’s year-ago sales were $173.6MFor the next quarter, 6 analysts are estimating revenue of $164.15M. There is a high estimate of $175.4M for the next quarter, whereas the lowest estimate is $141.5M.
A total of 6 analysts have provided revenue estimates for OPK’s current fiscal year. The highest revenue estimate was $649.8M, while the lowest revenue estimate was $584.26M, resulting in an average revenue estimate of $632.52M. In the same quarter a year ago, actual revenue was $713.1MBased on 6 analysts’ estimates, the company’s revenue will be $637.85M in the next fiscal year. The high estimate is $738.8M and the low estimate is $567.1M.
